NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.

双氯芬酸 医学 布洛芬 萘普生 安慰剂 罗非昔布 不利影响 内科学 心房颤动 临床试验 荟萃分析 相对风险 药理学 环氧合酶 置信区间 病理 替代医学 化学 酶 生物化学
出处
期刊:PubMed [National Institutes of Health]
卷期号:25 (167): 14-6 被引量:3
链接
标识
摘要

Nonsteroidal anti-inflammatory drugs (NSAIDs) used as analgesics expose patients to cardiovascular risks that can be predicted from their pharmacological properties. As of mid-2015, what is known about the cardiovascular harms of the NSAIDs of choice, ibuprofen and naproxen? Most of the data from comparative trials of NSAIDs concern cox-2 inhibitors, diclofenac, ibuprofen and naproxen. Few studies have addressed the serious cardiovascular effects of other NSAIDs. In 2013, a U.K. team published a large meta-analysis of hundreds of randomised trials comparing NSAIDs with placebo or one NSAID with another NSAID. Compared with placebo, a statistically significant increase in the risk of serious cardiovascular adverse effects was demonstrated with cox-2 inhibitors and with diclofenac (about +40%). This risk is mainly due to an increase in myocardial infarctions and vascular deaths. Another meta-analysis found similar results in terms of cardiovascular deaths. The results of epidemiological studies are consistent with those of randomised clinical trials. According to meta-analyses of randomised trials, high-dose ibuprofen increases cardiovascular risks to the same degree as diclofenac or cox-2 inhibitors. The risk seems to mainly apply to daily doses of 2400 mg, a finding borne out by epidemiological studies that showed no increased risk with ibuprofen 1200 mg. Two meta-analyses of clinical trials showed that all NSAIDs roughly double the risk of heart failure. One meta-analysis showed a small, statistically significant increase in the risk of atrial fibrillation. In practice, from a cardiovascular perspective, the NSAIDs of choice are ibuprofen, on condition that the dose does not exceed 1200 mg per day, and naproxen. In contrast, it would appear from the study data that cox-2 inhibitors, diclofenac and high-dose ibuprofen (2400 mg per day) are best avoided. As for other NSAIDs, the clinical data are too sparse to allow a meaningful comparison with the better studied NSAIDs. It is advisable to avoid using these other drugs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1900发布了新的文献求助10
刚刚
刚刚
1秒前
jiang完成签到 ,获得积分10
1秒前
1秒前
三分之二发布了新的文献求助10
2秒前
可爱的函函的应助被Huangzhisong采纳,获得10
2秒前
果郭发布了新的文献求助10
3秒前
流星发布了新的文献求助10
4秒前
4秒前
小星星完成签到,获得积分10
6秒前
金权富贵发布了新的文献求助10
7秒前
7秒前
lalala发布了新的文献求助10
8秒前
8秒前
8秒前
水煮电吹风的应助被parantal采纳,获得30
9秒前
迟迟发布了新的文献求助10
10秒前
hxy90完成签到,获得积分10
10秒前
11秒前
lqx完成签到,获得积分10
11秒前
金权富贵完成签到,获得积分10
11秒前
研友_VZG7GZ的应助被二马三乡采纳,获得10
11秒前
12秒前
小学鸡tut完成签到,获得积分10
12秒前
jhy发布了新的文献求助10
12秒前
13秒前
Huangzhisong发布了新的文献求助10
13秒前
嘟嘟完成签到 ,获得积分10
13秒前
Code_king发布了新的文献求助10
13秒前
潇洒夏菡完成签到,获得积分10
14秒前
ray发布了新的文献求助10
14秒前
aajhajkahna的应助被yy采纳,获得10
14秒前
彭于晏的应助被肉肉采纳,获得10
15秒前
三分之二发布了新的文献求助10
16秒前
null的应助被yy采纳,获得10
16秒前
yhzbmw完成签到,获得积分20
17秒前
17秒前
吕狗蛋完成签到,获得积分10
17秒前
lichong发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177667
求助须知:如何正确求助?哪些是违规求助? 9568537
关于积分的说明 21799700
捐赠科研通 7772307
什么是DOI,文献DOI怎么找? 3432429
关于科研通互助平台的介绍 2556651
邀请新用户注册赠送积分活动 2478011